+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer



Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer



Current Women's Health Reviews 5(1): 44-50




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063812211

Download citation: RISBibTeXText

DOI: 10.2174/157340409787721294


Related references

Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival. European Journal of Gynaecological Oncology 37(3): 305-311, 2016

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. Journal of Gynecologic Oncology 19(4): 223-228, 2008

Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer. Zhonghua Zhong Liu Za Zhi 30(4): 298-301, 2008

Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer. Cellular Physiology and Biochemistry 46(1): 178-186, 2018

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer. Journal of Oncology 2014: 312193, 2014

Platin sensitivity and long-term survival in Stage III epithelial ovarian cancer patients. European Journal of Gynaecological Oncology 29(5): 473-475, 2008

The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer. International Journal of Gynecological Cancer 14(1): 51-56, 2004

Long-term survival of patients with apparent early-stage (FIGO I-II) epithelial ovarian cancer: a population-based study. Gynecologic and Obstetric Investigation 63(3): 132-136, 2007

Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery. Acta Obstetricia et Gynecologica Scandinavica 98(1): 34-43, 2019

Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases only. European Journal of Gynaecological Oncology 33(6): 615-616, 2012

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. Clinicoeconomics and Outcomes Research 8: 397-406, 2016

Survival impact of complete cytoreductive surgery in the primary management of FIGO stage IIIC, high-grade, epithelial ovarian cancer. Journal of Clinical Oncology 26(15_Suppl): 16551-16551, 2016

Long-Term Tumor-Free Survival in a Patient with Stage IV Epithelial Ovarian Cancer Undergoing High-Dose Chemotherapy and Viscum album Extract Treatment: A Case Report. Permanente Journal 23: 18, 2018

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer. Radiology and Oncology 50(3): 341-346, 2016

Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer. Journal of Gynecologic Oncology 28(4): E48, 2017